SCHEDULE 13G: Capital Research Global Investors Discloses 5.8% Stake in Halliburton

Capital Research Global Investors has reported a 5.8% beneficial ownership stake in Halliburton Co., holding over 50 million shares as of June 30, 2025.

Summary

• Capital Research Global Investors (CRGI) has filed a Schedule 13G, disclosing beneficial ownership of 50,061,312 shares of Halliburton Co. Common Stock.
• This ownership represents 5.8% of Halliburton's outstanding common stock, based on 859,715,017 shares believed to be outstanding.
• CRGI, a division of Capital Research and Management Company, holds sole voting power over 50,061,245 shares and sole dispositive power over all 50,061,312 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The disclosure of a significant institutional stake by Capital Research Global Investors is generally viewed positively, indicating confidence in the issuer, Halliburton Co.

Positives

• A significant stake by a major institutional investor like Capital Research Global Investors can be interpreted as a vote of confidence in Halliburton's long-term prospects and management strategy.
• The acquisition of shares in the ordinary course of business suggests a strategic, passive investment rather than an activist position, which can provide stability.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may view this as a positive signal, potentially increasing investor confidence and attracting further institutional interest.
• The company's management might see this as validation of their strategy, given the passive nature of the investment.

Key Dates

Keywords

Halliburton, Capital Research Global Investors, beneficial ownership, SEC filing, 13G, institutional investment, common stock, oilfield services